Logo for Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals Investor Relations Material

Latest events

Logo for Syndax Pharmaceuticals Inc

Status Update

Syndax Pharmaceuticals
Logo for Syndax Pharmaceuticals

Status Update

9 Dec, 2024
Logo for Syndax Pharmaceuticals

FDA Announcement

15 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Syndax Pharmaceuticals Inc

Access all reports
Syndax Pharmaceuticals Inc. is a biopharmaceutical company focused on developing therapies for cancer. The company's lead programs target immune pathways and tumor microenvironments to enhance the body’s ability to fight cancer. Syndax's pipeline includes treatments for both solid tumors and hematologic cancers, aiming to address unmet medical needs by improving outcomes for cancer patients through novel combination therapies. The company is headquartered in Waltham, Massachusetts, and its shares are listed on the NASDAQ.